With our Phase IIa program underway and defined milestones in front of us, we look forward to engaging with investors and potential partners at BIO.” — Christer Rosén, Chairman and Chief Executive ...

The masses are not being policed, targeted, and incarcerated,” Distinguished Professor and author Dylan Rodríguez says; “it's ...

AUSTIN, TX / ACCESS Newswire / March 2, 2026 / In modern metabolic medicine, few treatments have reshaped care like GLP-1 ...

Oklahoma officials say drug distribution along I-35 and I-40 remains steady despite the death of Cartel Jalisco New ...

Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...

Did U.S. intelligence, bounties, and Trump pressure play a decisive role in the raid that killed CJNG boss El Mencho?

Ozempic and similar weight-loss medications are hailed as miracle drugs. But there are plenty of unknowns about long-term use ...

Evolent Health, Inc. is rated a Buy, with turnaround momentum and risk/reward now favoring upside after recent operational ...

Understanding how a healthy brain works can provide insight into how it fails, too. Scientists hope that studying organoids derived from humans with neurodevelopmental disorders — particularly ...

LifeMD (LFMD) looks deeply undervalued after a 55% drop. Preferred shares yield just under 10% and offer lower risk. See more ...